Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders

Journal of Child and Adolescent Psychopharmacology

Volumn 16, Issue 6, 2006, Pages 737-746

  Lee, Douglas O ^a   Ousley, Opal Y ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHD RATING SCALE; ADOLESCENT; ASPERGER SYNDROME; ATTENTION DEFICIT DISORDER; AUTISM; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; MALE; RATING SCALE; REVIEW; SCHOOL CHILD; SCORING SYSTEM; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

EID: 33846585912     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.16.737     Document Type: Review

References (37)

1. Aman M, Langworthy K: Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders. J Autism Dev Disord 30:451-459, 2000.
2. th edition (DSM-IV). Washington, DC, American Psychiatric Association, 1994.
3. Barkley RA, Fischer M, Edelbrock CS, Smallish L: The adolescent outcome of hyperactive children diagnosed by research criteria: I. an 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 29:546-557, 1990.
4. Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, Mennin D, Marrs A, Ouellette C, Moore P, Spencer T, Norman D, Wilens T, Kraus I, Perrin J: A prospective four-year follow-up study of attention deficit hyperactivity and related disorders. Arch Gen Psychiatry 53:437-446, 1996.
5. Biederman J, Mick E, Faraone SV: Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 157:816-818, 2000.
6. Burd L, Kerbeshian J, Westerland A, Labine J, Barth A, Klug MG, Wagner K: Prospective long-term follow-up of patients with pervasive developmental disorders. J Child Neurol 17:681-688, 2002.
7. Campbell M, Fish B, David R, Shapiro T, Collins P, Koh C: Response to triiodothyronine and dextroamphetamine: A study of preschool, schizophrenic children. J Autism Child Schiz 2:342-358, 1972.
8. Coles CD: Fetal alcohol exposure and attention: moving beyond ADHD. Alcohol Res Health 25:199-203, 2001.
9. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R, McGoey KE, Ikeda MJ: Teacher ratings of attention deficit hyperactivity disorder symptoms: Factor structure and normative data. Psychol Assess 9:436-444, 1997.
10. DuPaul GJ, Anastopoulos AD, Power TJ, Reid R, Ikeda MJ, McGoey KE: Parent ratings of attention-deficit/hyperactivity disorder symptoms: Factor structure and normative data. J Psychopath Behav Assess 20:83-102, 1998.
11. Ehlers S, Gillberg C: The epidemiology of Asperger syndrome. A total population study. J Child Psychol Psychiatry 34:1327-1350, 1993.
12. Faraone SV, Biederman J, Weber W, Russell RL: Psychiatric, neuropsychological, and psychosocial features of DSM-IV subtypes of attention-deficit/hyperactivity disorder; Results from a clinically referred sample. J Am Acad Child Adolesc Psychiatry 37:185-193, 1998.
13. Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R: Prevalence of pervasive developmental disorders in the British Nationwide survey of child mental health. J Am Acad Child Adolesc Psychiatry 40:820-827, 2001.
14. Frazier JA, Biederman J, Bellordre SB, Garfield SB, Geller DA, Coffey BJ, Faraone SV: Should the diagnosis of attention-deficit/hyperactivity disorder be considered in children with pervasive developmental disorder? J Atten Disord 4:203-211, 2001.
15. Geller B, Guttmacher L, Bleeg M: Coexistence of childhood onset pervasive developmental disorder and attention deficit disorder with hyperactivity. Am J Psychiatry 138:388-389, 1981.
16. Ghaziuddin M, Weidmer-Mikhail E, Ghaziuddin N: Comorbidity of Asperger syndrome: A preliminary report. J Intellect Disabil Res 42:279-283, 1998.
17. Gilliam JE: Gilliam Autism Rating Scale: Examiner's Manual. Austin (Texas), Pro-Ed, 1995.
18. Goldstein S, Schwebach AJ: The comorbidity of pervasive developmental disorder and attention deficit hyperactivity disorder: Results of retrospective chart review. J Autism Dev Disord 34:329-339, 2004.
19. Gomez R, Burns GL, Walsh JA, de Moura MA: A multitrait-multisource confirmatory factor analytic approach to the construct validity of ADHD rating scales. Psychol Assess 15:3-16, 2003.
20. Goodman R: The extended version of the Strengths and Difficulties Questionnaire as a guide to child psychiatric caseness and consequent burden. J Child Psychol Psychiatry 40:791-799, 1999.
21. Hart EL, Lahey BB, Loeber R, Applegate B, Frick PJ: Developmental change in attention-deficit hyperactivity disorder in boys: A four-year longitudinal study. J Abnorm Child Psychol 23:729-749, 1995.
22. Hollander E, Phillips AT, Yeh CC: Targeted treatments for symptom domains in child and adolescent autism. Lancet 362:732-74, 2003.
23. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988, 1997.
24. Klin A, Pauls D, Schultz R, Volkmar F: Three diagnostic approaches to Asperger Syndrome: Implications for research. J Autism Dev Dis 35:221-234, 2005.
25. Krug DA, Arick JR, Almond PJ: Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior. J Child Psych Psychiatry 21:221-229, 1980.
26. Kube DA, Petersen MC, Palmer FB: Attention deficit hyperactivity disorder: comorbidity and medication use. Clin Pediatr 41:461-469, 2002.
27. Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW, Barkley RA, Newcorn J, Jensen P, Richters J: DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 151:1673-1685, 1994.
28. Mitsis E, McKay KE, Schulz KP, Newcorn JH, Halperin JM: Parent-teacher concordance for DSM -IV attention-deficit/hyperactivity disorder in a clinic-referred sample. J Am Acad Child Adolesc Psychiatry 39:308-313, 2000.
29. Nam CB, Boyd M: Occupational status in 2000 Over a century of census-based measurement. Pop Res Policy Rev 23:327-358, 2004.
30. Nicolson R, Castellanos FX: Commentary: Considerations on the pharmacotherapy of attention deficits and hyperactivity in children with autism and other pervasive developmental disorders. J Aut Devel Disord 30:461-462, 2000.
31. Paternite CE, Loney J, Roberts MA: External validation of oppositional disorder and attention deficit disorder with hyperactivity. J Abnorm Child Psychol 23:453-471, 1995.
32. Pearson DA, Aman MG: Ratings of hyperactivity and developmental indices: Should clinicians correct for developmental level? J Autism Dev Disord 24:395-411, 1994.
33. Posey DJ, McDougle CJ: The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders. Harv Rev Psychiatry 8:45-63, 2000.
34. Rapport MD, Scanlan SW, Denney CB: Attention-deficit/hyperactivity disorder and scholastic achievement: A model of dual developmental pathways. J Child Psychol Psychiatr 40:1169-1183, 1999.
35. Steinhausen H, Drechsler R, Foldenyi M, Imhof K, Brandeis D: Clinical course of attention deficit/hyperactivity disorder from childhood toward early adolescence. J Am Acad Child Adolesc Psychiatry 42:1085-1092, 2003.
36. Wozniak J, Biederman J, Faraone SV, Frazier J, Kim J, Millstein R, Gershon J, Thornell A, Cha K, Snyder JB: Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry 36:1552-1559, 1997.
37. Yoshida Y, Uchiyama T: The clinical necessity for assessing attention deficit/hyperactivity disorder (AD/HD) symptoms in children with high-functioning pervasive developmental disorder (FDD). Eur Child Adolesc Psychiatry 13:307-314, 2004.